TORONTO, April 03, 2024 (GLOBE NEWSWIRE) -- HEALWELL AI Inc. (“HEALWELL” or the “Company”) (TSX: AIDX) (OTCQX: HWAIF), a healthcare technology company focused on AI and data science for preventative care, is pleased to announce that Dr. Alexander Dobranowski, CEO of HEALWELL AI, will be participating in the following upcoming investor conferences:
LD Micro Invitational XIV
Presentation Date: April 9, 2024
Presentation Time: 11:00 am ET (8:00 am PT) – Track 3
Hosted at the Sofitel New York from April 8-9, 2024, the 14th annual LD Micro Invitational introduces investors to presenting companies and provides the opportunity to meet with company management in 1-on-1 meetings. LD Micro, a wholly owned subsidiary of Freedom US Markets, was founded in 2006 with the sole purpose of being an independent resource in the micro-cap space. LD Micro’s mission is to serve as an invaluable asset for all those interested in finding the next generation of great companies.
For more information on LD Micro, visit www.ldmicro.com.
2024 BLOOM BURTON & CO. HEALTHCARE INVESTOR CONFERENCE
Presentation Date: April 17, 2024
Presentation Time: 3:30 pm ET (12:30 pm PT) – Room 104 C/D
Hosted at the Metro Toronto Convention Centre from April 16-17, 2024, this event introduces the latest developments in Canadian healthcare companies through inviting Canada’s premier publicly-traded and venture-backed private companies as well as the most promising pre-venture companies in the healthcare industry. Investors will have the opportunity to obtain corporate updates from presenting companies and participate in Bloom Burton’s 1-on-1 meeting system with company management.
For more information, please visit: https://www.bloomburton.com/conference/
Planet MicroCap Showcase: VEGAS 2024
Presentation Date: May 1, 2024
Presentation Time: 2:00 pm PT (5:00 pm ET) – Track 3
Webcast: https://www.webcaster4.com/Webcast/Page/3026/50168
Hosted at the Paris Hotel & Casino from April 30-May 2, 2024, the event brings together the best investors and thought leaders, and quality MicroCap investing opportunities. In addition to presenting, HEALWELL will also be conducting in-person 1-on-1 meetings at the conference venue on Thursday, May 2, 2024. Planet MicroCap is a global multimedia financial news, publishing and events company focused on news dissemination, providing information, data and analytics for the MicroCap investing community.
For more information, please visit: https://planetmicrocapshowcase.com/
Dr. Alexander Dobranowski
Chief Executive Officer
HEALWELL AI Inc.
About HEALWELL AI
HEALWELL is a healthcare technology company focused on AI and data science for preventative care. Its mission is to improve healthcare and save lives through early identification and detection of disease. Using its own proprietary technology, the Company is developing and commercializing advanced clinical decision support systems that can help healthcare providers detect rare and chronic diseases, improve efficiency of their practice and ultimately help improve patient health outcomes. HEALWELL is executing a strategy centered around developing and acquiring technology and clinical sciences capabilities that complement the Company's road map. HEALWELL is publicly traded on the Toronto Stock Exchange (the “TSX”) under the symbol “AIDX” and on the OTC Exchange under the symbol “HWAIF”. To learn more about HEALWELL, please visit https://healwell.ai/.
Disclaimer
Known and unknown risk factors, many of which are beyond the control of HEALWELL, could cause the actual results of HEALWELL to differ materially from the results, performance, achievements, or developments expressed or implied by such forward-looking statements. Such risk factors include but are not limited to those factors which are discussed under the section entitled “Risk Factors” in HEALWELL’s most recent annual information form dated April 1, 2024, which is available under HEALWELL’s SEDAR+ profile at www.sedarplus.ca. The risk factors are not intended to represent a complete list of the factors that could affect HEALWELL and the reader is cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking statements. There can be no assurance that forward looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Forward-looking statements are provided for the purpose of providing information about management’s expectations and plans relating to the future. HEALWELL disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, or to explain any material difference between subsequent actual events and such forward-looking statements, except to the extent required by applicable law. All of the forward-looking statements contained in this press release are qualified by these cautionary statements.
For more information:
Pardeep S. Sangha
Investor Relations, HEALWELL AI Inc.
Phone: 604-572-6392
This email address is being protected from spambots. You need JavaScript enabled to view it.
| Last Trade: | C$1.60 |
| Daily Change: | -0.08 -4.76 |
| Daily Volume: | 637,228 |
| Market Cap: | C$218.130M |
November 12, 2024 October 18, 2024 September 25, 2024 | |
Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....
CLICK TO LEARN MORE
ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MORE
